Education
About Us
Working with TipRanks
Follow Us
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
EMMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.13
Previous CloseN/A
Volume11.42K
Average Volume (3M)51.10K
Market Cap
$1.35M
Enterprise Value$36.13M
Total Cash (Recent Filing)$1.50M
Total Debt (Recent Filing)$600.20K
Price to Earnings (P/E)―
Beta78.38
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding63,865,570
10 Day Avg. Volume66,735
30 Day Avg. Volume51,105
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.07
Price to Cash Flow (P/CF)2.30
P/FCF Ratio0.20
Enterprise Value/Market Cap26.69
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.28
Enterprise Value/Ebitda39.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
25.45% Insiders
0.09% Other Institutional Investors
74.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EMMA FAQ
What was Emmaus Life Sciences Inc’s price range in the past 12 months?
Emmaus Life Sciences Inc lowest stock price was <$0.01 and its highest was $0.13 in the past 12 months.
What is Emmaus Life Sciences Inc’s market cap?
Emmaus Life Sciences Inc’s market cap is $1.35M.
When is Emmaus Life Sciences Inc’s upcoming earnings report date?
Emmaus Life Sciences Inc’s upcoming earnings report date is Mar 28, 2025 which is in 15 days.
How were Emmaus Life Sciences Inc’s earnings last quarter?
Emmaus Life Sciences Inc released its earnings results on Nov 19, 2024. The company reported $0.011 earnings per share for the quarter, beating the consensus estimate of N/A by $0.011.
Is Emmaus Life Sciences Inc overvalued?
According to Wall Street analysts Emmaus Life Sciences Inc’s price is currently Overvalued.
Does Emmaus Life Sciences Inc pay dividends?
Emmaus Life Sciences Inc does not currently pay dividends.
What is Emmaus Life Sciences Inc’s EPS estimate?
Emmaus Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emmaus Life Sciences Inc have?
Emmaus Life Sciences Inc has 63,865,570 shares outstanding.
What happened to Emmaus Life Sciences Inc’s price movement after its last earnings report?
Emmaus Life Sciences Inc reported an EPS of $0.011 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Emmaus Life Sciences Inc?
Currently, no hedge funds are holding shares in EMMA
---
Company Description
Emmaus Life Sciences Inc
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.
---
EMMA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---